Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
AstraZeneca
Cantor Fitzgerald
Deloitte
UBS
Mallinckrodt
Healthtrust
Colorcon
Chinese Patent Office

Generated: October 21, 2018

DrugPatentWatch Database Preview

PRAVASTATIN SODIUM - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for pravastatin sodium and what is the scope of pravastatin sodium freedom to operate?

Pravastatin sodium is the generic ingredient in two branded drugs marketed by Bristol Myers Squibb, Accord Hlthcare, Apotex Inc, Aurobindo Pharma Ltd, Cipla Ltd, Dr Reddys Labs Inc, Glenmark Generics, Lupin Pharms, Mylan, Mylan Pharms Inc, Pliva Hrvatska Doo, Ranbaxy Labs Ltd, Sandoz, Teva, Teva Pharms, Upsher-smith Labs, Watson Labs, and Zydus Pharms Usa, and is included in nineteen NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for pravastatin sodium. Forty-eight suppliers are listed for this compound. There are two tentative approvals for this compound.

Pharmacology for PRAVASTATIN SODIUM
Medical Subject Heading (MeSH) Categories for PRAVASTATIN SODIUM
Synonyms for PRAVASTATIN SODIUM
(?R,?R,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-?,?,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoic acid monosodium salt
(|AR, |AR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-|A, |A,6-trihydroxy-2-methyl-8[(2S)-2-methyl-1-oxobutoxyl]-1-naphthaleneheptanoic acid sodium hydrate
(|AR,|AR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-|A,|A,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoic Acid Sodium Salt
(betaR,deltaR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-beta,delta,6-trihydroxy-2-methyl-8[(2S)-2-methyl-1-oxobutoxyl]-1-naphthaleneheptanoic Acid Na
1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-2-methyl-8-(2-methyl-1-oxobutoxy)-beta,delta,6-trihydroxy-, monosodium salt, (1S-(1-alpha(beta-S*,delta-S*),2-alpha,6-alpha,8-beta(R*),8a-alpha))-
1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, monosodium salt, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-
115873-26-2
3-beta-Hydroxycompactin sodium salt
3beta-Hydroxycompactin, Na
3M8608UQ61
81093-37-0 (Parent)
81131-70-6
81131-73-9
85956-24-7
87098-76-8
AK150793
AKOS015896504
AKOS015964902
Aplactin
Bio-0081
Bristacol
C-22432
C23H35NaO7
C23H35O7.Na
CAS-81131-70-6
CC-33901
CCG-100926
CHEBI:8361
CHEMBL690
CPD000469187
CRES Pravastatin
CS-2003
CS-514
D00893
DRG-0319
DSSTox_CID_27525
DSSTox_GSID_47525
DSSTox_RID_82395
DTXSID6047525
Elisor
Epastatin sodium
Eptastatin sodium
Eptastatin sodium salt hydrate
HMS2051P05
HMS3268L20
HY-B0165A
I06-2463
Kopostat
Lipemol
Lipidal
Liplat
Lipostat
Liprevil
LS-94711
Mevalotin
MFCD00887601
MolPort-003-849-962
NC00176
NCGC00092370-01
NCGC00095183-01
NCGC00254232-01
P1796
Pralidon
Prareduct
Pravachol
Pravachol (TN)
Pravacol
Pravaselect
Pravasin
Pravasine
Pravastatin (sodium)
Pravastatin Natrium Mayrho Fer
Pravastatin sodium (JP17/USAN)
Pravastatin sodium [USAN:JAN]
Pravastatin sodium [USAN:USP:JAN]
Pravastatin Sodium Salt
Pravastatin sodium salt hydrate
Pravastatin sodium salt hydrate, >=98% (HPLC), powder
Pravastatin, Sodium Salt
PubChem21972
s3036
SAM001246656
Sanaprav
SC-46788
SCHEMBL3013
Selektine
Selipran
Sodium (+)-(betaR,deltaR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-hexahydro-beta,delta,6,8-tetrahydroxy-2-methyl-1-naphthaleneheptanoate, 8-((2S)-2-methylbutyrate)
sodium (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoate
sodium;(3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate
SQ 31000
SQ-31000
ST2407537
Tox21_111474
Tox21_300270
UNII-3M8608UQ61
Vasen
VWBQYTRBTXKKOG-IYNICTALSA-M
Tentative approvals for PRAVASTATIN SODIUM
Applicant Application No. Strength Dosage Form
➤ Sign Up➤ Sign Up80MGTABLET;ORAL
➤ Sign Up➤ Sign Up40MGTABLET;ORAL
➤ Sign Up➤ Sign Up20MGTABLET;ORAL

US Patents and Regulatory Information for PRAVASTATIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb PRAVACHOL pravastatin sodium TABLET;ORAL 019898-004 Mar 22, 1993 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ranbaxy Labs Ltd PRAVASTATIN SODIUM pravastatin sodium TABLET;ORAL 076445-001 Apr 23, 2007 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb PRAVACHOL pravastatin sodium TABLET;ORAL 019898-003 Oct 31, 1991 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Upsher-smith Labs PRAVASTATIN SODIUM pravastatin sodium TABLET;ORAL 209869-004 Apr 13, 2018 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glenmark Generics PRAVASTATIN SODIUM pravastatin sodium TABLET;ORAL 077987-001 May 11, 2007 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for PRAVASTATIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol Myers Squibb PRAVACHOL pravastatin sodium TABLET;ORAL 019898-003 Oct 31, 1991 ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb PRAVACHOL pravastatin sodium TABLET;ORAL 019898-008 Dec 18, 2001 ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb PRAVACHOL pravastatin sodium TABLET;ORAL 019898-008 Dec 18, 2001 ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb PRAVACHOL pravastatin sodium TABLET;ORAL 019898-002 Oct 31, 1991 ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb PRAVACHOL pravastatin sodium TABLET;ORAL 019898-003 Oct 31, 1991 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
AstraZeneca
Cantor Fitzgerald
Deloitte
UBS
Mallinckrodt
Healthtrust
Colorcon
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.